1015 Chestnut Street
Suite M-100 Mezzanine
Philadelphia, PA 19107
(215) 503-7806
(215) 503-3804 fax
Suite M-100 Mezzanine
Philadelphia, PA 19107
(215) 503-7806
(215) 503-3804 fax
Most Recent Peer-reviewed Publications
- Preoperative Platelet Count Associates with Survival and Distant Metastasis in Surgically Resected Colorectal Cancer Patients
- A phase i study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas
- Population and target considerations for triple-negative breast cancer clinical trials
- Guanylyl cyclase C as a biomarker in colorectal cancer
- Early results of prostate cancer radiation therapy: An analysis with emphasis on research strategies to improve treatment delivery and outcomes
- A Dual-Institution Randomized Controlled Trial of Remnant Closure after Distal Pancreatectomy: Does the Addition of a Falciform Patch and Fibrin Glue Improve Outcomes?
- Circadian Gene Expression and Clinicopathologic Correlates in Pancreatic Cancer
- Genetic variations in stem cell-related genes and colorectal cancer prognosis
- Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes
- Prognostic factors and outcomes after definitive treatment of female urethral cancer: A population-based analysis
- Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma
- Analytic lymph node number establishes staging accuracy by occult tumor burden in colorectal cancer
- GUCY2C molecular staging personalizes colorectal cancer patient management
- Occult tumor burden contributes to racial disparities in stage-specific colorectal cancer outcomes
- Molecular staging individualizing cancer management
- c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells
- GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity
- Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma
- Comparative effectiveness research for prostate cancer radiation therapy: Current status and future directions
- A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies